Sarmal is a genomics company innovating affordable sequencing and rapid nucleic acid diagnostics.
Sarmal has raised $5.0M in total funding. The most recent round was Undisclosed. The last funding was announced in January 2026.
Sarmal is headquartered in La Jolla, United States.
Sarmal is a genomics company innovating affordable sequencing and rapid nucleic acid diagnostics.
Sarmal is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sarmal — Funding & Investors." VCBacked, January 26, 2026, https://www.vcbacked.co/company/sarmal. Accessed August 15, 2026.
VCBacked. (2026). Sarmal — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/sarmal
{{cite web |title=Sarmal — Funding & Investors |url=https://www.vcbacked.co/company/sarmal |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated